Our Fill-Finish Capabilities
Blow-Fill-Seal
30+ years of BFS manufacturing experience. 7 lines, 200M+ annual units, EU Annex 1 compliant. 40+ presentations: ophthalmic, inhalation, irrigation, injectable, and diluent formats.
Explore Blow-Fill-Seal
Sterile Vial Filling
Validated filling environments spanning terminal sterilization, RABS aseptic filling, and an EU Annex 1 compliant robotic isolator, matched to the sterility assurance requirements of each molecule and market.
Explore Sterile Vial Filling
Pre-Filled Syringes and Cartridges
EU Annex 1 compliant robotic aseptic filling via the SA25 Cytiva isolator, purpose-built for biologics, orphan drug, and clinical supply programs.
Explore Pre-Filled Syringes
Oral Liquids
Commercial-scale oral liquid manufacturing across syrups, solutions, and suspensions, including controlled substances and specialized containment programs.
Explore Oral Liquids
Packaging
From filled container to market-ready finished goods, including serialization and track-and-trace for commercial products, all within one GMP environment.
Explore Packaging
Specialized Services
Cytotoxic
More than 30 years of dedicated cytotoxic manufacturing expertise, with containment capability up to OEB5 and a purpose-built oncology facility.
Explore Cytotoxic
Controlled Substances
Active manufacturing licences for Australian Schedule 8 substances, with vault storage, diversion controls, and chain of custody protocols embedded as standard operational practice.
Explore Controlled Substances
Diluent
High-volume sterile diluent manufacturing for WFI and sodium chloride formulations, with multi-jurisdictional approvals and global supply scale.
Explore Diluent
Biosimilars and Generics
End-to-end manufacturing for biosimilar and generic injectable programs, with microbial fermentation and fill-finish under one partner, one project management interface, and one regulatory dossier.
Explore Biosimilars and Generics
From Formulation to Commercial Delivery

Formulation and Process Design
Every program begins with your molecule. Formulation, analytical development, and regulatory strategy aligned before manufacturing begins.

Engineering and
Scale-Up
Container closure integrity qualification and engineering batch manufacture establish the process confidence your program needs to progress.

cGMP Manufacture
and Release
GMP fill-finish in the environment matched to your molecule, with in-process controls, visual inspection, and QC release under one roof. Approximately 9 months from project start to cGMP batch release.

Finished Goods
and Dispatch
Labelling, serialization, and cartoning within one GMP environment. Products prepared for ex-works dispatch, ready for global market distribution.
Why BioCina for Your Fill-Finish Program
Our team has spent decades manufacturing sterile drug products for hospitals, healthcare systems, and pharmaceutical companies across 100+ countries. We understand the scale, the sterility demands, and the regulatory complexity that fill-finish programs require.
Proven at
Commercial Scale
Decades of experience across development and launch of recombinant proteins, with a growing and well-equipped platform spanning nucleic acid therapeutics and lipid-based delivery systems.
Regulatory Credentials That Open Markets
Our regulatory approvals span FDA, EMA, TGA, Health Canada, ANVISA, and PMDA, giving every program manufactured at BioCina access to the world's most demanding pharmaceutical markets.
Clinical to Commercial. One Partner.
From early clinical supply to full commercial manufacturing, every stage of your program supported end-to-end under one partner.
Built Around
Your Program
Proven, standardized workflows with the flexibility to design individual approaches when your program requires it. Every fill-finish approach is designed around the specific scientific, regulatory, and commercial requirements of your drug product, with the right environment, format, and regulatory strategy determined from day one.
Drug Product Manufacturing Track Record
0+ years
of Sterile Manufacturing Heritage
0M+ units
Annual Capacity


0+
Approved Products
0+
Countries Delivered

Ready to Scale Your Drug Product Program?
Let’s talk about your fill-finish needs and how we can deliver.

